Plunkett Research Online: Protalix BioTherapeutics, Inc.

PROTALIX BIOTHERAPEUTICS, INC. (PLX:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Protalix is a biopharmaceutical company that hopes to revolutionize the development and manufacturing of recombinant therapeutic proteins through its ProCellEx® plant cell-based protein expression system. Using ProCellEx, Protalix is developing a proprietary pipeline of novel and biosimilar recombin.....



Protalix BioTherapeutics, Inc.
Ticker: PLX
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972 49889488
Fax:
Address: 2 Snunit Street
Science Park, POB 455
Carmiel, 20100 Israel

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
Yossi MaimonCFO/Chief Accounting Officer/Secretary/Treasurer/Vice President
Zeev BronfeldDirector
See More
Protalix is a biopharmaceutical company that hopes to revolutionize the development and manufacturing of recombinant therapeutic proteins through its ProCellEx® plant cell-based protein expression system. Using ProCellEx, Protalix is developing a proprietary pipeline of novel and biosimilar recombin.....See More See More

Auditor: Kesselman & Kesselman
Legal Advisor: Morrison & Foerster LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: